| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/22/2003 | US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating |
| 04/22/2003 | US6552169 Density enhanced protein tyrosine phosphatases |
| 04/22/2003 | US6551991 Recombinant proteins derived from HGF and MSP |
| 04/22/2003 | US6551989 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/22/2003 | US6551827 Methods for producing and transforming cassave protoplasts |
| 04/22/2003 | US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 04/22/2003 | US6551823 EBV-infected stomach cancer cell line |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551821 Brain cyclic nucleotide gated ion channel and uses thereof |
| 04/22/2003 | US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant |
| 04/22/2003 | US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase |
| 04/22/2003 | US6551807 Producing a ketocarotenoid in a host cell, by transfecting with nucleotide sequence for expression of carotenoid ketolase |
| 04/22/2003 | US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 04/22/2003 | US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 04/22/2003 | US6551774 Determining the presence or amount of telomerase within a sample obtained from said patient, and correlating the amount of telomerase with a condition associated with an elevated level of telomerase activity |
| 04/22/2003 | US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/22/2003 | US6551772 Model for viral infection and immune response |
| 04/22/2003 | US6551625 Inhibiting disagreeable odors with extracts of undifferentiated plant cells |
| 04/22/2003 | US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 04/22/2003 | US6551589 Obtaining cell derived antigens (CDAs) from the body as well as mononuclear cells to be placed in the body; reacting mononuclear cells in vitro with the CDAs and recovering those that do not bind the antigens; prevent graft vs host disease |
| 04/22/2003 | US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy |
| 04/22/2003 | US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 04/22/2003 | CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
| 04/22/2003 | CA2152941C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/22/2003 | CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 04/22/2003 | CA2098295C G protein-coupled glutamate receptors |
| 04/18/2003 | CA2404050A1 Mb-1 analogs and uses thereof |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031938A2 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 04/17/2003 | WO2003031643A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 04/17/2003 | WO2003031640A2 Preadipocyte cell strains and uses therefore |
| 04/17/2003 | WO2003031633A2 Adenoviral vector system |
| 04/17/2003 | WO2003031630A1 Multi-cistronic vectors for gene transfer protocols |
| 04/17/2003 | WO2003031629A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | WO2003031612A2 Method for determining cell cycle position |
| 04/17/2003 | WO2003031608A2 Mutated abl kinase domains |
| 04/17/2003 | WO2003031604A1 Gastrointestinal chemosensory receptors |
| 04/17/2003 | WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof |
| 04/17/2003 | WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031579A2 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | WO2003031573A2 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/17/2003 | WO2003031570A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031567A2 Precursor conversion screening methods |
| 04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
| 04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
| 04/17/2003 | WO2003031473A1 Leukocyte inactivation module |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003030965A2 Artificial lymph node |
| 04/17/2003 | WO2003030959A1 Corneal repair device |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003030719A2 Methods and kits for use in selecting approaches to treating cancer |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002074965A3 Characterization of the i-spoml endonuclease from fission yeast |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002064804A3 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 04/17/2003 | WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 04/17/2003 | WO2002059248A9 A novel gene associated with regulation of adiposity and insulin response |
| 04/17/2003 | WO2002057664A3 Bacillus thuringiensis insecticidal proteins |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002032960A3 Methods of selecting compounds for modulation of bladder function |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO2002000721A3 Cytokine receptor zcytor17 |
| 04/17/2003 | WO2001098366A3 Enterokinase cleavage sequences and their use |
| 04/17/2003 | WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | US20030074699 Nucleotide sequences coding polypeptide for use in controlling flowering in plants |
| 04/17/2003 | US20030074698 Method for modifying plant morphology, biochemistry and physiology |
| 04/17/2003 | US20030074696 Method for increasing stress-resistance to a plant |
| 04/17/2003 | US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein |
| 04/17/2003 | US20030074690 Novel plastid-targeting nucleic acid sequence, a novel beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
| 04/17/2003 | US20030074684 Control of gene expression |
| 04/17/2003 | US20030073829 Nucleotide sequences coding polypeptides for use in the treatment of eating disorders |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073822 Blood group antigen fusion polypeptides and method of use thereof |
| 04/17/2003 | US20030073821 Antibody for use in human therapeutics and diagnostics |
| 04/17/2003 | US20030073819 PGC-1, a novel brown fat PPARgamma coactivator |
| 04/17/2003 | US20030073817 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |